[Lumbo-aortic lymphadenectomy in ovarian cancers].
Systematic lumbo-aortic lymphadenectomy has revealed the importance of lymphatic dissemination of ovarian cancers: the incidence of lumbo-aortic metastases reported in the literature is high (15 to 25% of so-called early stages, false stage I and II). An exact staging assessment is an essential prognostic factor; underestimation of apparently early stages leads to insufficient treatment, reducing the long-term survival rate. The correlation with intraperitoneal extension, the degree of differentiation and the histological type is only partial. Retroperitoneal lymph node invasion has a prognostic significance at each stage. Lastly, lumbo-aortic lymphadenectomy appears to provide a specific therapeutic benefit as part of maximal tumour reduction surgery.
Bonnier
P
P
Service de Gynécologie et Obstétrique A, Hôpital de la Conception, Marseille.
Piana
L
L
D005260:Female; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods*; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology*; D011183:Postoperative Complications; D011379:Prognosis; D012186:Retroperitoneal Neoplasms / Q000401:mortality / Q000556:secondary / Q000601:surgery*
La lymphadénectomie lombo-aortique dans les cancers de l'ovaire.